EUVIMEDObjevte EUVIMED
Leserbrief

Patients with piperacillin–tazobactam allergy labels tolerate other beta‐lactams

Michael Taggart iD, Mark Hew iD, Celia Zubrinich iD

Clinical & Experimental Allergy · 2024-07 · 54 (7) · 521-523

DOI: 10.1111/cea.14490 ↗

At a glance

Leserbrief in Clinical & Experimental Allergy, published online on 2024-05-02. Written by Michael Taggart and 2 co-authors. Institution: Allergy, Asthma and Clinical Immunology, The Alfred, Melbourne, Victoria, Australia. Major MEDLINE topics: Drug Hypersensitivity, Piperacillin, Tazobactam Drug Combination, beta-Lactams, Anti-Bacterial Agents. Cited 6 times so far (Crossref); 9 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

were selectively sensitised to piperacillin-tazobactam. 9 Twelve of these patients were challenged to alternative penicillins and there were no reactions.6 Of the eight immediate-type reactors sensitised to other penicillins, no drug challenges were performed, and therefore, the number with true allergy to alternative penicillins is uncertain.While this 'real-world' cohort outside of highly selected populations attending allergy clinics represents the largest characterised group with piperacillin-tazobactam allergy labels to date, it is possible that treating clinicians only administered alternative beta-lactams to those with lower risk allergy histories.However, the proportion of patients whose index reaction label was consistent with anaphylaxis did not significantly differ between those who were administered another beta-lactam and those who were not.The majority who were not administered another beta-lactam simply had not required any further beta-lactam treatment (22/36, 61.1%).Almost all patients with non-SCAR piperacillin-tazobactam allergy labels were able to tolerate other beta-lactams during routine clinical care without prior skin testing.This was true even for those with a history of an immediatetype index reaction where >98% of alternative beta-lactams were tolerated.

Subjects

MeSH terms (MEDLINE)

Drug HypersensitivityPiperacillin, Tazobactam Drug Combinationbeta-LactamsAnti-Bacterial AgentsHumansMaleFemaleMiddle AgedAgedDrug LabelingAdultPiperacillin

Substances

Piperacillin, Tazobactam Drug Combinationbeta-LactamsAnti-Bacterial AgentsPiperacillin

Authors and institutions

  • Allergy, Asthma and Clinical Immunology, The Alfred, Melbourne, Victoria, Australia.

ORCID profiles: Michael Taggart, Mark Hew, Celia Zubrinich

Cite

APA

Taggart, M., Hew, M., & Zubrinich, C. (2024). Patients with piperacillin–tazobactam allergy labels tolerate other beta‐lactams. Clinical & Experimental Allergy, 54(7), 521-523. https://doi.org/10.1111/cea.14490

Vancouver

Taggart M, Hew M, Zubrinich C. Patients with piperacillin–tazobactam allergy labels tolerate other beta‐lactams. Clinical & Experimental Allergy. 2024;54(7):521-523. doi:10.1111/cea.14490

BibTeX
@article{Taggart2024,
  author = {Taggart, Michael and Hew, Mark and Zubrinich, Celia},
  title = {Patients with piperacillin–tazobactam allergy labels tolerate other beta‐lactams},
  journal = {Clinical & Experimental Allergy},
  year = {2024},
  volume = {54},
  number = {7},
  pages = {521--523},
  doi = {10.1111/cea.14490}
}
Start for free →